Literature DB >> 4040428

Evaluation of a combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens.

R Rosell, A Abad-Esteve, M Ribas-Mundo, I Moreno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4040428

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.

Authors:  R Rosell; J Carles; A Abad; J M Jimeno; I Moreno; A Barnadas; N Ribelles; N Haboubi
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

2.  A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting.

Authors:  F Roila; C Basurto; V Minotti; E Ballatori; M Tonato
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.